Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription Articles published in Biochem Biophys Res Commun Retrieve available abstracts of 103 articles: HTML format

Single Articles

October 2021
1. BARAL P, Bhattarai N, Hossen ML, Stebliankin V, et al
   Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.
   Biochem Biophys Res Commun. 2021;574:14-19.
   PubMed     Abstract available
   
   
   September 2021
2. LONG Y, Song S, Luo F, Han X, et al
   A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.
   Biochem Biophys Res Commun. 2021;571:152-158.
   PubMed     Abstract available
   
   
   
3. BEGUM F, Srivastava AK, Ray U
   Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
   Biochem Biophys Res Commun. 2021;571:26-31.
   PubMed     Abstract available
   
   
   
4. OBA M, Rongduo W, Saito A, Okabayashi T, et al
   Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro.
   Biochem Biophys Res Commun. 2021;570:21-25.
   PubMed     Abstract available
   
   
   August 2021
5. RYU DK, Song R, Kim M, Kim YI, et al
   Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
   Biochem Biophys Res Commun. 2021;566:135-140.
   PubMed     Abstract available
   
   
   
6. JIN D, Wei J, Sun J
   Analysis of the molecular mechanism of SARS-CoV-2 antibodies.
   Biochem Biophys Res Commun. 2021;566:45-52.
   PubMed     Abstract available
   
   
   
7. HUANG RY, Herr DR
   Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein.
   Biochem Biophys Res Commun. 2021;565:8-13.
   PubMed     Abstract available
   
   
   July 2021
8. OHKI S, Imamura T, Higashimura Y, Matsumoto K, et al
   Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.
   Biochem Biophys Res Commun. 2021;563:92-97.
   PubMed     Abstract available
   
   
   June 2021
9. HATAKEYAMA D, Masuda T, Miki R, Ohtsuki S, et al
   In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
   Biochem Biophys Res Commun. 2021;557:273-279.
   PubMed     Abstract available
   
   
   
10. ZHAO L, Hao Y, Song Z, Fan Y, et al
    TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
    Biochem Biophys Res Commun. 2021;556:87-92.
    PubMed     Abstract available
    
    
    May 2021
11. PADHI AK, Tripathi T
    Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
    Biochem Biophys Res Commun. 2021;555:147-153.
    PubMed     Abstract available
    
    
    
12. VANDYCK K, Abdelnabi R, Gupta K, Jochmans D, et al
    ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model.
    Biochem Biophys Res Commun. 2021;555:134-139.
    PubMed     Abstract available
    
    
    
13. CAO B, Kang T
    Nonlinear adaptive control of COVID-19 with media campaigns and treatment.
    Biochem Biophys Res Commun. 2021;555:202-209.
    PubMed     Abstract available
    
    
    
14. IDREES D, Kumar V
    SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
    Biochem Biophys Res Commun. 2021;554:94-98.
    PubMed     Abstract available
    
    
    
15. KRUSE RL, Huang Y, Smetana H, Gehrie EA, et al
    A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;553:165-171.
    PubMed     Abstract available
    
    
    
16. ZHANG Y, Niu G, Flisikowska T, Schnieke A, et al
    A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs.
    Biochem Biophys Res Commun. 2021;553:25-29.
    PubMed     Abstract available
    
    
    April 2021
17. PEREIRA F
    SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
    Biochem Biophys Res Commun. 2021;550:8-14.
    PubMed     Abstract available
    
    
    March 2021
18. SHIBUYA M, Tamiya S, Kawai A, Yoshioka Y, et al
    Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
    Biochem Biophys Res Commun. 2021;554:166-172.
    PubMed     Abstract available
    
    
    
19. SAKURAI Y, Ngwe Tun MM, Kurosaki Y, Sakura T, et al
    5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
    Biochem Biophys Res Commun. 2021;545:203-207.
    PubMed     Abstract available
    
    
    
20. ADAMI EA, Chavez Rico SL, Akamatsu MA, Miyaki C, et al
    H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.
    Biochem Biophys Res Commun. 2021;545:145-149.
    PubMed     Abstract available
    
    
    
21. SMITS VAJ, Hernandez-Carralero E, Paz-Cabrera MC, Cabrera E, et al
    The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
    Biochem Biophys Res Commun. 2021;543:45-49.
    PubMed     Abstract available
    
    
    January 2021
22. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;538:231-237.
    PubMed     Abstract available
    
    
    
23. SANTORO MG, Carafoli E
    Remdesivir: From Ebola to COVID-19.
    Biochem Biophys Res Commun. 2021;538:145-150.
    PubMed     Abstract available
    
    
    
24. MOORE KM, Suthar MS
    Comprehensive analysis of COVID-19 during pregnancy.
    Biochem Biophys Res Commun. 2021;538:180-186.
    PubMed     Abstract available
    
    
    
25. VIANELLO C, Strozzi F, Mocellin P, Cimetta E, et al
    A perspective on early detection systems models for COVID-19 spreading.
    Biochem Biophys Res Commun. 2021;538:244-252.
    PubMed     Abstract available
    
    
    
26. PASETTO D, Lemaitre JC, Bertuzzo E, Gatto M, et al
    Range of reproduction number estimates for COVID-19 spread.
    Biochem Biophys Res Commun. 2021;538:253-258.
    PubMed     Abstract available
    
    
    
27. JANS DA, Wagstaff KM
    The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
    Biochem Biophys Res Commun. 2021;538:163-172.
    PubMed     Abstract available
    
    
    
28. REZNIKOV LR, Norris MH, Vashisht R, Bluhm AP, et al
    Identification of antiviral antihistamines for COVID-19 repurposing.
    Biochem Biophys Res Commun. 2021;538:173-179.
    PubMed     Abstract available
    
    
    
29. SANTOPOLO S, Riccio A, Santoro MG
    The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Biochem Biophys Res Commun. 2021;538:80-87.
    PubMed     Abstract available
    
    
    
30. BACCA E, Digaetano M, Meschiari M, Franceschini E, et al
    Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.
    Biochem Biophys Res Commun. 2021;538:151-155.
    PubMed     Abstract available
    
    
    
31. WATASHI K
    Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
    Biochem Biophys Res Commun. 2021;538:137-144.
    PubMed     Abstract available
    
    
    
32. WALSH MA, Grimes JM, Stuart DI
    Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics.
    Biochem Biophys Res Commun. 2021;538:40-46.
    PubMed     Abstract available
    
    
    
33. MOURIER T, Sadykov M, Carr MJ, Gonzalez G, et al
    Host-directed editing of the SARS-CoV-2 genome.
    Biochem Biophys Res Commun. 2021;538:35-39.
    PubMed     Abstract available
    
    
    
34. CHENG HY, Huang AS
    Proactive and blended approach for COVID-19 control in Taiwan.
    Biochem Biophys Res Commun. 2021;538:238-243.
    PubMed     Abstract available
    
    
    
35. KALFAOGLU B, Almeida-Santos J, Tye CA, Satou Y, et al
    T-cell dysregulation in COVID-19.
    Biochem Biophys Res Commun. 2021;538:204-210.
    PubMed     Abstract available
    
    
    
36. JACKSON CB, Zhang L, Farzan M, Choe H, et al
    Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
    Biochem Biophys Res Commun. 2021;538:108-115.
    PubMed     Abstract available
    
    
    
37. KENNY G, Mallon PW
    COVID19- clinical presentation and therapeutic considerations.
    Biochem Biophys Res Commun. 2021;538:125-131.
    PubMed     Abstract available
    
    
    
38. SCHENKELBERG T
    Vaccine-induced protection in aging adults and pandemic response.
    Biochem Biophys Res Commun. 2021;538:218-220.
    PubMed    
    
    
    
39. PLATTO S, Wang Y, Zhou J, Carafoli E, et al
    History of the COVID-19 pandemic: Origin, explosion, worldwide spreading.
    Biochem Biophys Res Commun. 2021;538:14-23.
    PubMed     Abstract available
    
    
    
40. GROVES DC, Rowland-Jones SL, Angyal A
    The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
    Biochem Biophys Res Commun. 2021;538:104-107.
    PubMed     Abstract available
    
    
    
41. GIOVANETTI M, Benedetti F, Campisi G, Ciccozzi A, et al
    Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.
    Biochem Biophys Res Commun. 2021;538:88-91.
    PubMed     Abstract available
    
    
    
42. DIPIAZZA AT, Graham BS, Ruckwardt TJ
    T cell immunity to SARS-CoV-2 following natural infection and vaccination.
    Biochem Biophys Res Commun. 2021;538:211-217.
    PubMed     Abstract available
    
    
    
43. CARRILLO J, Izquierdo-Useros N, Avila-Nieto C, Pradenas E, et al
    Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
    Biochem Biophys Res Commun. 2021;538:187-191.
    PubMed     Abstract available
    
    
    
44. SARVER DC, Wong GW
    Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19.
    Biochem Biophys Res Commun. 2021;538:92-96.
    PubMed     Abstract available
    
    
    
45. BAXTER C, Abdool Karim Q, Abdool Karim SS
    Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives.
    Biochem Biophys Res Commun. 2021;538:221-225.
    PubMed    
    
    
    
46. LAI CKC, Lam W
    Laboratory testing for the diagnosis of COVID-19.
    Biochem Biophys Res Commun. 2021;538:226-230.
    PubMed     Abstract available
    
    
    
47. FANTINI J, Chahinian H, Yahi N
    Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
    Biochem Biophys Res Commun. 2021;538:132-136.
    PubMed     Abstract available
    
    
    
48. PLATTO S, Zhou J, Wang Y, Wang H, et al
    Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease.
    Biochem Biophys Res Commun. 2021;538:2-13.
    PubMed     Abstract available
    
    
    
49. ZINZULA L, Basquin J, Bohn S, Beck F, et al
    High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
    Biochem Biophys Res Commun. 2021;538:54-62.
    PubMed     Abstract available
    
    
    
50. CARAFOLI E
    Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection.
    Biochem Biophys Res Commun. 2021;538:156-162.
    PubMed     Abstract available
    
    
    
51. JIANG Y, Yin W, Xu HE
    RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
    Biochem Biophys Res Commun. 2021;538:47-53.
    PubMed     Abstract available
    
    
    
52. 
    Editorial.
    Biochem Biophys Res Commun. 2021;538:1.
    PubMed    
    
    
    
53. CHAKRABORTY S
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;538:97-103.
    PubMed     Abstract available
    
    
    
54. GU L, Zhou Y, Wang G, Deng H, et al
    Spatial learning and memory impaired after infection of non-neurotropic influenza virus in BALB/c male mice.
    Biochem Biophys Res Commun. 2021;540:29-36.
    PubMed     Abstract available
    
    
    
55. SHARMA A, Preece B, Swann H, Fan X, et al
    Structural stability of SARS-CoV-2 virus like particles degrades with temperature.
    Biochem Biophys Res Commun. 2021;534:343-346.
    PubMed     Abstract available
    
    
    
56. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;534:830-836.
    PubMed     Abstract available
    
    
    
57. LIMA MA, Skidmore M, Khanim F, Richardson A, et al
    Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2.
    Biochem Biophys Res Commun. 2021;534:485-490.
    PubMed     Abstract available
    
    
    
58. CHAKRABORTY S
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;534:374-380.
    PubMed     Abstract available
    
    
    November 2020
59. JEREMIAH SS, Miyakawa K, Morita T, Yamaoka Y, et al
    Potent antiviral effect of silver nanoparticles on SARS-CoV-2.
    Biochem Biophys Res Commun. 2020;533:195-200.
    PubMed     Abstract available
    
    
    October 2020
60. TUNG HYL, Limtung P
    Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.
    Biochem Biophys Res Commun. 2020;532:134-138.
    PubMed     Abstract available
    
    
    September 2020
61. CHEN P, Zeng Z, Du H
    Establishment and validation of a drug-target microarray for SARS-CoV-2.
    Biochem Biophys Res Commun. 2020;530:4-9.
    PubMed     Abstract available
    
    
    
62. SINGH TOMAR PP, Arkin IT
    SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
    Biochem Biophys Res Commun. 2020;530:10-14.
    PubMed     Abstract available
    
    
    
63. TAKEDA Y, Uchiumi H, Matsuda S, Ogawa H, et al
    Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus.
    Biochem Biophys Res Commun. 2020;530:1-3.
    PubMed     Abstract available
    
    
    
64. XU H, Qian J, Song Y, Ming D, et al
    The adaptability of H9N2 avian influenza A virus to humans: A comparative docking simulation study.
    Biochem Biophys Res Commun. 2020;529:963-969.
    PubMed     Abstract available
    
    
    August 2020
65. ZHANG H, Tu J, Cao C, Yang T, et al
    Proteasome activator PA28gamma-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
    Biochem Biophys Res Commun. 2020;529:251-256.
    PubMed     Abstract available
    
    
    July 2020
66. CHOI JY, Lee HK, Park JH, Cho SJ, et al
    Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.
    Biochem Biophys Res Commun. 2020;528:413-419.
    PubMed     Abstract available
    
    
    
67. BONGINI P, Trezza A, Bianchini M, Spiga O, et al
    A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization.
    Biochem Biophys Res Commun. 2020;528:35-38.
    PubMed     Abstract available
    
    
    
68. WAKIDA H, Kawata K, Yamaji Y, Hattori E, et al
    Stability of RNA sequences derived from the coronavirus genome in human cells.
    Biochem Biophys Res Commun. 2020;527:993-999.
    PubMed     Abstract available
    
    
    June 2020
69. ZENG W, Liu G, Ma H, Zhao D, et al
    Biochemical characterization of SARS-CoV-2 nucleocapsid protein.
    Biochem Biophys Res Commun. 2020;527:618-623.
    PubMed     Abstract available
    
    
    
70. OTHMAN H, Bouslama Z, Brandenburg JT, da Rocha J, et al
    Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.
    Biochem Biophys Res Commun. 2020;527:702-708.
    PubMed     Abstract available
    
    
    
71. LI Y, Li H, Zhou L
    EZH2-mediated H3K27me3 inhibits ACE2 expression.
    Biochem Biophys Res Commun. 2020;526:947-952.
    PubMed     Abstract available
    
    
    May 2020
72. LUAN J, Lu Y, Jin X, Zhang L, et al
    Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.
    Biochem Biophys Res Commun. 2020;526:165-169.
    PubMed     Abstract available
    
    
    
73. QI F, Qian S, Zhang S, Zhang Z, et al
    Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
    Biochem Biophys Res Commun. 2020;526:135-140.
    PubMed     Abstract available
    
    
    April 2020
74. HUANG Q, Zhong Y, Li J, Ye Y, et al
    Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication.
    Biochem Biophys Res Commun. 2020 Apr 13. pii: S0006-291X(20)30756.
    PubMed     Abstract available
    
    
    February 2020
75. MORRIS AK, Wang Z, Ivey AL, Xie Y, et al
    Cellular mRNA export factor UAP56 recognizes nucleic acid binding site of influenza virus NP protein.
    Biochem Biophys Res Commun. 2020 Feb 19. pii: S0006-291X(20)30327.
    PubMed     Abstract available
    
    
    December 2019
76. CHEN F, Yang L, Huang Y, Chen Y, et al
    Isocorilagin, isolated from Canarium album (Lour.) Raeusch, as a potent neuraminidase inhibitor against influenza A virus.
    Biochem Biophys Res Commun. 2019 Dec 13. pii: S0006-291X(19)32363.
    PubMed     Abstract available
    
    
    October 2019
77. NISHIOKA K, Daidoji T, Nakaya T
    Demethylation around the transcriptional start site of the IFN-beta gene induces IFN-beta production and protection against influenza virus infection.
    Biochem Biophys Res Commun. 2019 Oct 5. pii: S0006-291X(19)31874.
    PubMed     Abstract available
    
    
    August 2019
78. YAN L, Wang H, Sun L, Liu Y, et al
    An epitope on the stem region of hemagglutinin of H1N1 influenza A virus recognized by neutralizing monoclonal antibody.
    Biochem Biophys Res Commun. 2019 Aug 14. pii: S0006-291X(19)31572.
    PubMed     Abstract available
    
    
    
79. SHEN Q, Cho JH
    The structure and conformational plasticity of the nonstructural protein 1 of the 1918 influenza A virus.
    Biochem Biophys Res Commun. 2019 Aug 14. pii: S0006-291X(19)31538.
    PubMed     Abstract available
    
    
    July 2019
80. JUNG Y, Kong B, Moon S, Yu SH, et al
    Envelope-deforming antiviral peptide derived from influenza virus M2 protein.
    Biochem Biophys Res Commun. 2019 Jul 30. pii: S0006-291X(19)31442.
    PubMed     Abstract available
    
    
    June 2019
81. CHEN Q, Huang X, Wei R, Zhang L, et al
    Characterization of influenza virus PR8 strain cultured in embryonated eggs by cryo-electron tomography.
    Biochem Biophys Res Commun. 2019 Jun 10. pii: S0006-291X(19)31059.
    PubMed     Abstract available
    
    
    April 2019
82. NAMKOONG H, Ishii M, Fujii H, Asami T, et al
    Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice.
    Biochem Biophys Res Commun. 2019 Apr 6. pii: S0006-291X(19)30618.
    PubMed     Abstract available
    
    
    
83. SUN L, Li H, Sun J, Guo C, et al
    Antibodies against H1N1 influenza virus hemagglutinin cross-react with prohibitin.
    Biochem Biophys Res Commun. 2019 Apr 6. pii: S0006-291X(19)30595.
    PubMed     Abstract available
    
    
    March 2019
84. ZHU Y, Shao Y, Qu X, Guo J, et al
    Sodium ferulate protects against influenza virus infection by activation of the TLR7/9-MyD88-IRF7 signaling pathway and inhibition of the NF-kappaB signaling pathway.
    Biochem Biophys Res Commun. 2019 Mar 27. pii: S0006-291X(19)30502.
    PubMed     Abstract available
    
    
    
85. YAMAMOTO Y, Tamiya S, Shibuya M, Nakase I, et al
    Peptides with the multibasic cleavage site of the hemagglutinin from highly pathogenic influenza viruses act as cell-penetrating via binding to heparan sulfate and neuropilins.
    Biochem Biophys Res Commun. 2019 Mar 20. pii: S0006-291X(19)30451.
    PubMed     Abstract available
    
    
    December 2018
86. YI E, Oh J, Kang HR, Song MJ, et al
    BST2 inhibits infection of influenza A virus by promoting apoptosis of infected cells.
    Biochem Biophys Res Commun. 2018 Dec 26. pii: S0006-291X(18)32759.
    PubMed     Abstract available
    
    
    November 2018
87. TAKEDA Y, Takaki H, Fukui-Miyazaki A, Yoshida S, et al
    Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination.
    Biochem Biophys Res Commun. 2018 Nov 4. pii: S0006-291X(18)32350.
    PubMed     Abstract available
    
    
    August 2018
88. WANG B, Zhang Y, Jiang W, Zhu L, et al
    GALNT3 inhibits NF-kappaB signaling during influenza A virus infection.
    Biochem Biophys Res Commun. 2018 Aug 9. pii: S0006-291X(18)31740.
    PubMed     Abstract available
    
    
    July 2018
89. WANG J, Liu M, Ding N, Li Y, et al
    Vaccine based on antibody-dependent cell-mediated cytotoxicity epitope on the H1N1 influenza virus increases mortality in vaccinated mice.
    Biochem Biophys Res Commun. 2018 Jul 28. pii: S0006-291X(18)31633.
    PubMed     Abstract available
    
    
    June 2018
90. TANG Z, Zang N, Fu Y, Ye Z, et al
    HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice.
    Biochem Biophys Res Commun. 2018;501:1-8.
    PubMed     Abstract available
    
    
    May 2018
91. MURALIDHARAN A, Gravel C, Duran A, Larocque L, et al
    Identification of immunodominant CD8 epitope in the stalk domain of influenza B viral hemagglutinin.
    Biochem Biophys Res Commun. 2018 May 21. pii: S0006-291X(18)31217.
    PubMed     Abstract available
    
    
    March 2018
92. JUNG KI, Pyo CW, Choi SY
    Influenza A virus-induced autophagy contributes to enhancement of virus infectivity by SOD1 downregulation in alveolar epithelial cells.
    Biochem Biophys Res Commun. 2018 Mar 16. pii: S0006-291X(18)30581.
    PubMed     Abstract available
    
    
    
93. TAKAHASHI H, Nagata S, Odagiri T, Kageyama T, et al
    Establishment of the cross-clade antigen detection system for H5 subtype influenza viruses using peptide monoclonal antibodies specific for influenza virus H5 hemagglutinin.
    Biochem Biophys Res Commun. 2018 Mar 7. pii: S0006-291X(18)30532.
    PubMed     Abstract available
    
    
    February 2018
94. SHINDE A, Luo J, Bharathi SS, Shi H, et al
    Increased mortality from influenza infection in long-chain acyl-CoA dehydrogenase knockout mice.
    Biochem Biophys Res Commun. 2018 Feb 16. pii: S0006-291X(18)30366.
    PubMed     Abstract available
    
    
    October 2017
95. CHO J, Yi H, Jang EY, Lee MS, et al
    Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
    Biochem Biophys Res Commun. 2017 Oct 7. pii: S0006-291X(17)32007.
    PubMed     Abstract available
    
    
    September 2017
96. NAKASHIMA A, Suzuki K, Asayama Y, Konno M, et al
    Oral administration of Euglena gracilis Z and its carbohydrate storage substance provides survival protection against influenza virus infection in mice.
    Biochem Biophys Res Commun. 2017 Sep 30. pii: S0006-291X(17)31957.
    PubMed     Abstract available
    
    
    
97. KIM YJ, Ko EJ, Kim MC, Lee YN, et al
    Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.
    Biochem Biophys Res Commun. 2017 Sep 5. pii: S0006-291X(17)31771.
    PubMed     Abstract available
    
    
    
98. MA JH, Song SH, Guo M, Zhou J, et al
    Long-term exposure to PM2.5 lowers influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediates histones modification in IL-6 and IFN-beta promoter regions.
    Biochem Biophys Res Commun. 2017 Sep 5. pii: S0006-291X(17)31772.
    PubMed     Abstract available
    
    
    August 2017
99. PANG LL, Yuan XH, Shao CS, Li MZ, et al
    The suppression of innate immune response by human rhinovirus C.
    Biochem Biophys Res Commun. 2017;490:22-28.
    PubMed     Abstract available
    
    
    May 2017
100. YAMASHITA N, Yashiro M, Ogawa H, Namba H, et al
     Metabolic pathway catalyzed by Vanin-1 pantetheinase plays a suppressive role in influenza virus replication in human alveolar epithelial A549 cells.
     Biochem Biophys Res Commun. 2017 May 30. pii: S0006-291X(17)31081.
     PubMed     Abstract available
     
     
     December 2016
101. FENG W, Sun X, Shi N, Zhang M, et al
     Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response.
     Biochem Biophys Res Commun. 2016 Dec 1. pii: S0006-291X(16)32040.
     PubMed     Abstract available
     
     
     September 2016
102. MORI T, Nakamura K, Masaoka K, Fujita Y, et al
     Cleavage of influenza RNA by using a human PUF-based artificial RNA-binding protein-staphylococcal nuclease hybrid.
     Biochem Biophys Res Commun. 2016 Sep 28. pii: S0006-291X(16)31616.
     PubMed     Abstract available
     
     
     
103. PARK S, Lee I, Kim JI, Bae JY, et al
     Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A(H7N9) virus in guinea pigs.
     Biochem Biophys Res Commun. 2016 Sep 6. pii: S0006-291X(16)31471.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: